Key facts
- This page summarizes Rebecca Chambers's Form 4 filing for Outset Medical, Inc. (OM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2021, 16:02.
Rebecca Chambers - 24 Jun 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- OM
- Reported as of
- 24 Jun 2021
- Net transaction value
- -$743,830
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2021, 16:02:55 UTC
- Prior SEC filing
- 22 Jun 2021
- Next SEC filing
- 20 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- By: John L Brottem For: Rebecca Chambers
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rebecca Chambers filed Form 4 for Outset Medical, Inc. (OM) on 25 Jun 2021.
Change
- Previous filing in this sequence was filed on 22 Jun 2021.
- Current net transaction value: -$743,830.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OM
transaction
Common Stock
Options Exercise
- Transaction value
- $104,544
- Shares
- +16,727
- Change %
- +123%
- Price
- $6.25
- Shares after
- 30,324
- Date
- 24 Jun 2021
- Ownership
- Direct
OM
transaction
Common Stock
Sale
- Transaction value
- $848,373
- Shares
- -16,727
- Change %
- -55%
- Price
- $50.72
- Shares after
- 13,597
- Date
- 24 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OM
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -16,727
- Change %
- -18%
- Price
- $0.000000
- Shares after
- 77,745
- Date
- 24 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,727
- Exercise price
- $6.25
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $50.32 to $51.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
This option vests 25% on June 3, 2020 and then in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date.